After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.

Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have earned a consensus rating of “Buy” from the six ...

After hours: February 7 at 6:45:05 PM EST Loading Chart for LXEO ...

Dr. Sarah Hernandez is the Director of Research Programs at the Hereditary Disease Foundation (HDF). She carried out her postdoctoral work with Dr. Leslie Thompson at the University of California, ...